Pharma’s Almanac: What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Dec 15, 2023 | In the News

Click here to view...

BioWorld Insider Podcast: Six biopharma executives consider a tough 2023 and are hopeful for a better 2024

Dec 11, 2023 | In the News

Click here to view...

Reuters: Emcure wins dismissal of US lawsuit over COVID-19 vaccine trade secrets

Dec 5, 2023 | In the News

Click here to view...

Law360: Wash. Judge Nixes HDT’s $950M mRNA Vax Trade Secrets

Dec 4, 2023 | In the News

Click here to view...

HDT Bio to Participate in World Vaccine Congress West Coast 2023

Nov 16, 2023 | Press Releases

SEATTLE, Nov. 16, 2023 /PRNewswire/ — HDT Bio Corp., a clinical-stage private company developing advanced RNA products to treat and prevent infectious diseases and cancer, today announced its participation at the World Vaccine Congress West Coast 2023 in Santa...